Restaging Transurethral Resection for Non-Muscle Invasive Bladder Cancer. Who, Why, When, and How?

Chad R. Ritch, Peter E. Clark, Todd M. Morgan

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

The rate of clinical understaging in non-muscle invasive bladder cancer (NMIBC) after an initial transurethral resection (TUR) is significant, particularly for high-grade disease, and this has a major impact on prognosis. A repeat TUR, 2 to 6 weeks following the initial resection, is recommended in appropriately selected cases to avoid diagnostic inaccuracy and improve treatment allocation. This article summarizes the rationale and indications for performing a repeat TUR in NMIBC and also provides information regarding patient selection and technique.

Original languageEnglish (US)
Pages (from-to)295-304
Number of pages10
JournalUrologic Clinics of North America
Volume40
Issue number2
DOIs
StatePublished - May 1 2013
Externally publishedYes

Keywords

  • Non-muscle invasive bladder cancer
  • Repeat resection
  • Restaging
  • Second-look cystoscopy
  • Transurethral resection
  • Understaging
  • Upstaging

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Restaging Transurethral Resection for Non-Muscle Invasive Bladder Cancer. Who, Why, When, and How?'. Together they form a unique fingerprint.

  • Cite this